ADAMA Provides Financial Performance Estimation for the Full Year of
2024
TEL AVIV, ISRAEL and BEIJING, CHINA, January 22, 2025 – ADAMA Ltd. (the “Company”) (SZSE 000553),
today provided an estimate regarding its financial performance for the full year of 2024. In early 2024, ADAMA
launched 'Fight Forward', a strategic transformation plan aimed at gradually delivering improved profit and
cash-targets over a three-year period. Improvements in certain key metrics, including free cash flow and
adjusted financial results in 2024, reflect the plan's initial impact.
Sales
For the full year of 2024, ADAMA is expecting to report a decline in revenues of approximately 7% to 16% in
USD to $3,934 million to $4,348 million (28 billion to 31 billion RMB), compared to the full year of 2023. The
lower revenues mainly reflect lower prices in 2024, due to just-in-time purchasing patterns of the channel in
light of price volatility and a higher interest rate environment, despite improved channel inventory levels.
Volumes in Q4 2024 were up compared with Q4 2023 despite the Company’s shift away from selected
low-profit products, marking the second consecutive quarter of volume growth.
Adjusted EBITDA and Net Loss
For the full year of 2024, the Company is expecting to report an increase in adjusted EBITDA and in its margin,
in comparison to the full year of 2023. Despite the decrease in revenues, adjusted EBITDA and its margin
improved due to an increase in the gross margin, mainly reflecting the positive impact of lower costs of new
inventory sold, an improved sales mix towards higher-margin products, and continued control of operating
expenses, all following implementation of the Fight Forward plan.
The Company expects to report an adjusted net loss in the range of USD 151 million to 261 million for the full
year of 2024, compared to a loss of USD 236 million for the full year of 2023. The loss is attributable to higher
adjusted operating profit and a decrease in financial expenses, in light of lower interest paid on loans, lower
put option revaluation, as well as the net impact of a lower Israeli CPI on the ILS-denominated CPI-linked
bonds, despite higher tax expenses.
Adjusted Net Loss Estimated Full Year 2023
Full Year 2024
Net loss attributable to shareholders (USD (261)-(151) (236)
millions)
Earnings per share (USD) (0.112)-(0.0648) (0.1013)
Net loss attributable to shareholders (RMB (1,860)-(1,073) (1,691)
millions)
Earnings per share (RMB) (0.7982)-(0.4604) (0.7260)
Adjusted Net loss excludes the impact of transitory, non-operational or non-cash items, mainly including:
i. Non-cash amortization charges in respect of transfer assets received from Syngenta related to the
2017 ChemChina-Syngenta acquisition;
ii. Non-cash amortization net charges related to intangible assets created as part of the Purchase Price
Allocation (PPA) on acquisitions, with no impact on the ongoing performance of the companies
acquired;
iii. Restructuring costs incurred as part of the implementation of the Fight Forward transformation plan;
iv. Fixed asset impairment related to improvement of operational efficiency, as part of the Fight Forward
plan;
v. Provisions such as legal claims, registration impairment and update of registration depreciation;
vi. Soil and water cleanup and remediation;
vii. Financial expenses including non-cash adjustments related to revaluation of put options attributed to
minority stakes in subsidiaries, and expenses deriving from tax claims surcharges and inflation.
Reported EBITDA and Net Loss
The Company expects lower reported EBITDA and deepened reported net loss (which include the impact of
the above adjusted items) for the full year of 2024 compared to 2023. This expectation is mainly due to lower
reported operating profit and a higher tax burden, despite a decrease in financial expenses as explained above.
Reported Net Loss Estimated Full Year 2023
Full Year 2024
Net loss attributable to shareholders (USD (470)-(360) (225)
millions)
Earnings per share (USD) (0.2017)-(0.1545) (0.0964)
Net loss attributable to shareholders (RMB (3,351)-(2,564) (1,606)
millions)
Earnings per share (RMB) (1.4384)-(1.1006) (0.6893)
The estimated results of the Company are a preliminary estimation of the Company and have not been audited
or reviewed by certified accountants. However, the Company and the external auditor have preliminarily
communicated regarding relevant matters of the performance
